November 9, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has selected 12 late-breaking clinical trials and 16 first report Investigations that are guaranteed to impact patient care and future directions in cardiovascular technologies.
Monday, October 30 - Main Arena I
Late-Breaking Clinical Trials 1
First Report Investigations 1
Tuesday, October 31, 2017 - Main Arena II
Late-Breaking Clinical Trials 2: Co-sponsored by the Lancet
First Report Investigations 2
Wednesday, November 1, 2017 - Main Arena III
Late-Breaking Clinical Trial 3: Co-sponsored by the Journal of the American Medical Association
First Report Investigations 3
Thursday, November 2, 2017 - Main Arena IV
Late-Breaking Clinical Trials 4
First Report Investigations 4
Other Studies, Videos and Articles From TCT 2017
VIDEO: What Went Wrong With the Absorb Stent? – discussion on the Absorb trials at TCT 2017 with Ajay Kirtane, M.D.
VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis – with Philippe Genereux, M.D.
VIDEO: Overview of the National Cardiogenic Shock Initiative — with William W. O’Neill, M.D.
VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke — with John Rhodes, M.D.
VIDEO: Update of Mitral Valve Repair and Replacement Technologies — with Ted Feldman, M.D.
VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch — with Juan Granada, M.D.
VIDEO: Converting to Bundled Payments for PCI — with Peter Duffy, M.D.
For more information: www.crf.org/tct/agenda/2017-late-breaking-trials-and-first-report-investigations
Links to Late-breaking Trials at Other Meetings:
SCAI 2017 Late-Breaking Clinical Trial Presentations
Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials
October 31, 2025 
